VIDEO: AbbVie presents emerging data on Rinvoq, Skyrizi clinical trials

VIDEO: AbbVie presents emerging data on Rinvoq, Skyrizi clinical trials

In a video exclusive, Remo Panaccione, MD, University of Calgary, outlined new therapeutic data for the treatment of patients with inflammatory bowel diseases at the 16th Congress of European Crohn’s and Colitis Organisation.Highlighted studies included the U-ACHIEVE and U-ACCOMPLISH phase 3 therapeutic induction studies in which researchers evaluated the safety and efficacy of Rinvoq (upadacitinib)…

Study finds ‘strikingly high’ antibiotic resistance among urine E. coli isolates in US

Study finds ‘strikingly high’ antibiotic resistance among urine E. coli isolates in US

There was a “strikingly high” level of antibiotic resistance among outpatient urine Escherichia coli isolates collected during a recent 9-year period in the United States, according to a study published in Clinical Infectious Diseases.“These data demonstrate the high prevalence of nonsusceptible E. coli, with significant variation in resistance depending on geographic location within the U.S….